Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas
<p>Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in terms of incidence and deaths in the United States and Europe. NHLs are a heterogeneous cancer group including several haematological neoplasias with different degree of aggressiveness. In spite of the progresses,...
Сохранить в:
Главные авторы: | Massimo Bortolotti (Автор), Letizia Polito (Автор) |
---|---|
Формат: | |
Опубликовано: |
Global Journal of Cancer Therapy - Peertechz Publications,
2015-03-10.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma
по: Camila Bezerra Melo Figueirêdo, и др.
Опубликовано: (2014) -
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
по: Firas Badin, и др.
Опубликовано: (2010) -
Rituximab-induced interstitial pneumonitis in patient with non-Hodgkin lymphoma: a clinical case
по: Nikolai A. Ognerubov, и др.
Опубликовано: (2022) -
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
по: Natalie S. Grover, и др.
Опубликовано: (2015) -
Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey
по: William H. Baer II, и др.
Опубликовано: (2014)